SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
23-Jan-23 8:00 PM View: | Aptose Biosciences Inc. (APTO) | 19-Jan-23 | Grant | 150,000 | -- | -- | 41% 363.25K to 513.25K | |
21-Sep-22 6:07 PM View: | Aptose Biosciences Inc. (APTO) | 19-Sep-22 | Private Purchase | 10,000 | $0.68 | $6,834.00 | 3% 353.25K to 363.25K | |
06-Jun-22 4:13 PM View: | Aptose Biosciences Inc. (APTO) | 06-Jun-22 | Private Purchase | 10,000 | $0.97 | $9,681.00 | 3% 343.25K to 353.25K | |
17-Dec-21 1:38 PM View: | Aptose Biosciences Inc. (APTO) | 16-Dec-21 | Market Purchase | 13,183 | $1.52 | $20,038.20 | 4% 330.07K to 343.25K | (3%) |
15-Dec-21 1:48 PM View: | Aptose Biosciences Inc. (APTO) | 15-Dec-21 | Market Purchase | 17,822 | $1.12 | $19,960.60 | 6% 312.25K to 330.07K | (< 1%) |
29-Nov-21 11:53 AM View: | Aptose Biosciences Inc. (APTO) | 26-Nov-21 | Market Purchase | 8,643 | $2.31 | $19,965.30 | 3% 303.6K to 312.25K | (1%) |
06-Jul-21 5:07 PM View: | Aptose Biosciences Inc. (APTO) | 02-Jul-21 | Market Purchase | 6,081 | $3.29 | $19,998.00 | 2% 297.52K to 303.6K | 2% |
10-Jul-20 6:55 PM View: | Aptose Biosciences Inc. (APTO) | 10-Jul-20 | Market Sale | 168,891 | $6.05 | $1,021,790.00 | (36%) 466.41K to 297.52K | 30% |
26-Mar-20 1:10 PM View: | Aptose Biosciences Inc. (APTO) | 25-Mar-20 | Market Purchase | 3,400 | $5.82 | $19,803.00 | < 1% 463.01K to 466.41K | (27%) |
12-Mar-20 4:21 PM View: | Aptose Biosciences Inc. (APTO) | 10-Mar-20 | Grant | 300,000 | -- | -- | 184% 163.01K to 463.01K | |
28-Oct-19 1:59 PM View: | Aptose Biosciences Inc. (APTO) | 24-Oct-19 | Market Purchase | 10,000 | $1.92 | $19,200.00 | 7% 153.01K to 163.01K | 123% |
19-Apr-19 2:35 PM View: | Aptose Biosciences Inc. (APTO) | 18-Apr-19 | Market Purchase | 10,000 | $1.85 | $18,507.00 | 7% 143.01K to 153.01K | 132% |
15-Mar-19 4:35 PM View: | Aptose Biosciences Inc. (APTO) | 14-Mar-19 | Market Purchase | 10,000 | $1.90 | $18,993.00 | 8% 133.01K to 143.01K | 126% |